DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Gujarat Themis Biosyn Limited — Board Meeting Intimation

NSE 3d ago·27 Aug 2026, 1:21 pm

Gujarat Themis Biosyn

Gujarat Themis Biosyn has announced a board meeting scheduled for September 1, 2026, to discuss a potential fund-raising plan. This is a standard corporate procedure where the company's directors review its financial needs and decide on the best way to raise capital.

For investors, this development is significant as it signals the company's intent to strengthen its financial position. Depending on the outcome, it could be used for expansion, debt repayment, or general corporate purposes, which may impact the stock's valuation in the future.

Investors should wait for the official announcement after the meeting to understand the specific details, such as the purpose of the funds and the expected amount. This information will be crucial in assessing the potential impact on the company's growth prospects.